ID   PCFT_HUMAN              Reviewed;         459 AA.
AC   Q96NT5; Q1HE20; Q86T92; Q8TEG3; Q96FL0;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   10-MAY-2017, entry version 131.
DE   RecName: Full=Proton-coupled folate transporter;
DE   AltName: Full=G21;
DE   AltName: Full=Heme carrier protein 1;
DE   AltName: Full=PCFT/HCP1;
DE   AltName: Full=Solute carrier family 46 member 1;
GN   Name=SLC46A1; Synonyms=HCP1, PCFT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 269-459 (ISOFORM 2).
RC   TISSUE=Glial tumor, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 199-459 (ISOFORM 1).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16143108; DOI=10.1016/j.cell.2005.06.025;
RA   Shayeghi M., Latunde-Dada G.O., Oakhill J.S., Laftah A.H.,
RA   Takeuchi K., Halliday N., Khan Y., Warley A., McCann F.E., Hider R.C.,
RA   Frazer D.M., Anderson G.J., Vulpe C.D., Simpson R.J., McKie A.T.;
RT   "Identification of an intestinal heme transporter.";
RL   Cell 122:789-801(2005).
RN   [6]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INVOLVEMENT IN HFM.
RX   PubMed=17129779; DOI=10.1016/j.cell.2006.09.041;
RA   Qiu A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E.,
RA   Sandoval C., Zhao R., Akabas M.H., Goldman I.D.;
RT   "Identification of an intestinal folate transporter and the molecular
RT   basis for hereditary folate malabsorption.";
RL   Cell 127:917-928(2006).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17156779; DOI=10.1016/j.febslet.2006.11.048;
RA   Latunde-Dada G.O., Takeuchi K., Simpson R.J., McKie A.T.;
RT   "Haem carrier protein 1 (HCP1): expression and functional studies in
RT   cultured cells.";
RL   FEBS Lett. 580:6865-6870(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND VARIANTS HFM SER-113; ARG-147;
RP   ARG-318; TRP-376 AND ARG-425.
RX   PubMed=17446347; DOI=10.1182/blood-2007-02-077099;
RA   Zhao R., Min S.H., Qiu A., Sakaris A., Goldberg G.L., Sandoval C.,
RA   Malatack J.J., Rosenblatt D.S., Goldman I.D.;
RT   "The spectrum of mutations in the PCFT gene, coding for an intestinal
RT   folate transporter, that are the basis for hereditary folate
RT   malabsorption.";
RL   Blood 110:1147-1152(2007).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=17335806; DOI=10.1016/j.yexcr.2007.01.019;
RA   Sharma S., Dimasi D., Broeer S., Kumar R., Della N.G.;
RT   "Heme carrier protein 1 (HCP1) expression and functional analysis in
RT   the retina and retinal pigment epithelium.";
RL   Exp. Cell Res. 313:1251-1259(2007).
RN   [10]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR LOCATION.
RX   PubMed=17475902; DOI=10.1124/jpet.107.122606;
RA   Nakai Y., Inoue K., Abe N., Hatakeyama M., Ohta K.-Y., Otagiri M.,
RA   Hayashi Y., Yuasa H.;
RT   "Functional characterization of human proton-coupled folate
RT   transporter/heme carrier protein 1 heterologously expressed in
RT   mammalian cells as a folate transporter.";
RL   J. Pharmacol. Exp. Ther. 322:469-476(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-58.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-458, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=23601781; DOI=10.1111/febs.12293;
RA   Duddempudi P.K., Nakashe P., Blanton M.P., Jansen M.;
RT   "The monomeric state of the proton-coupled folate transporter
RT   represents the functional unit in the plasma membrane.";
RL   FEBS J. 280:2900-2915(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-458, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND GLYCOSYLATION AT ASN-58 AND
RP   ASN-68.
RX   PubMed=25053408; DOI=10.1074/jbc.M114.578252;
RA   Wilson M.R., Hou Z., Matherly L.H.;
RT   "Substituted cysteine accessibility reveals a novel transmembrane 2-3
RT   reentrant loop and functional role for transmembrane domain 2 in the
RT   human proton-coupled folate transporter.";
RL   J. Biol. Chem. 289:25287-25295(2014).
RN   [19]
RP   VARIANT HFM CYS-113, AND CHARACTERIZATION OF VARIANT HFM CYS-113.
RX   PubMed=18559978; DOI=10.1182/blood-2008-04-150276;
RA   Lasry I., Berman B., Straussberg R., Sofer Y., Bessler H., Sharkia M.,
RA   Glaser F., Jansen G., Drori S., Assaraf Y.G.;
RT   "A novel loss-of-function mutation in the proton-coupled folate
RT   transporter from a patient with hereditary folate malabsorption
RT   reveals that Arg 113 is crucial for function.";
RL   Blood 112:2055-2061(2008).
RN   [20]
RP   VARIANT HFM GLN-376, CHARACTERIZATION OF VARIANT HFM GLN-376, AND
RP   MUTAGENESIS OF ARG-376.
RX   PubMed=20686069; DOI=10.1152/ajpcell.00113.2010;
RA   Mahadeo K., Diop-Bove N., Shin D., Unal E.S., Teo J., Zhao R.,
RA   Chang M.H., Fulterer A., Romero M.F., Goldman I.D.;
RT   "Properties of the Arg376 residue of the proton-coupled folate
RT   transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary
RT   folate malabsorption.";
RL   Am. J. Physiol. 299:C1153-C1161(2010).
RN   [21]
RP   VARIANT HFM TYR-156, CHARACTERIZATION OF VARIANT HFM TYR-156, AND
RP   MUTAGENESIS OF ASP-109 AND ASP-156.
RX   PubMed=20805364; DOI=10.1182/blood-2010-06-291237;
RA   Shin D.S., Min S.H., Russell L., Zhao R., Fiser A., Goldman I.D.;
RT   "Functional roles of aspartate residues of the proton-coupled folate
RT   transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate
RT   malabsorption.";
RL   Blood 116:5162-5169(2010).
RN   [22]
RP   VARIANTS HFM ASP-335 AND ARG-338, AND CHARACTERIZATION OF VARIANTS HFM
RP   ASP-335 AND ARG-338.
RX   PubMed=21333572; DOI=10.1016/j.ymgme.2011.01.008;
RA   Shin D.S., Mahadeo K., Min S.H., Diop-Bove N., Clayton P., Zhao R.,
RA   Goldman I.D.;
RT   "Identification of novel mutations in the proton-coupled folate
RT   transporter (PCFT-SLC46A1) associated with hereditary folate
RT   malabsorption.";
RL   Mol. Genet. Metab. 103:33-37(2011).
CC   -!- FUNCTION: Has been shown to act both as an intestinal proton-
CC       coupled high-affinity folate transporter and as an intestinal heme
CC       transporter which mediates heme uptake from the gut lumen into
CC       duodenal epithelial cells. The iron is then released from heme and
CC       may be transported into the bloodstream. Dietary heme iron is an
CC       important nutritional source of iron. Shows a higher affinity for
CC       folate than heme. {ECO:0000269|PubMed:17129779,
CC       ECO:0000269|PubMed:17156779, ECO:0000269|PubMed:17446347,
CC       ECO:0000269|PubMed:17475902}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.3 uM for folic acid (at pH 5.5)
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC         KM=1.5 uM for folic acid (at pH 6.0)
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC         KM=2.7 uM for folic acid (at pH 6.5)
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC         KM=6.0 uM for folic acid (at pH 7.0)
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC         KM=56.2 uM for folic acid (at pH 7.5)
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC       pH dependence:
CC         Optimum pH is 4.0-5.5. Activity decreases above pH 5.5 and
CC         reaches negligible levels at neutral pH and above.
CC         {ECO:0000269|PubMed:17129779, ECO:0000269|PubMed:17475902};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23601781}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane; Multi-pass membrane
CC       protein. Cytoplasm {ECO:0000250}. Note=Localizes to the apical
CC       membrane of intestinal cells in iron-deficient cells, while it
CC       resides in the cytoplasm in iron-replete cells. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96NT5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96NT5-2; Sequence=VSP_016053;
CC         Note=Inactive isoform which results in impaired folate
CC         absorption, giving rise to hereditary folate malabsorption
CC         (HFM).;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, liver, placenta, small
CC       intestine, spleen, retina and retinal pigment epithelium. Lower
CC       levels found in colon and testis. Very low levels in brain, lung,
CC       stomach, heart and muscle. In intestine, expressed in duodenum
CC       with lower levels in jejunum, ileum, cecum, rectum and segments of
CC       the colon. {ECO:0000269|PubMed:17129779,
CC       ECO:0000269|PubMed:17335806}.
CC   -!- DISEASE: Hereditary folate malabsorption (HFM) [MIM:229050]: Rare
CC       autosomal recessive disorder characterized by impaired intestinal
CC       folate absorption with folate deficiency resulting in anemia,
CC       hypoimmunoglobulinemia with recurrent infections, and recurrent or
CC       chronic diarrhea. In many patients, neurological abnormalities
CC       such as seizures or mental retardation become apparent during
CC       early childhood, attributed to impaired transport of folates into
CC       the central nervous system. When diagnosed early, the disorder can
CC       be treated by administration of folate. If untreated, it can be
CC       fatal and, if treatment is delayed, the neurological defects can
CC       become permanent. {ECO:0000269|PubMed:17129779,
CC       ECO:0000269|PubMed:17446347, ECO:0000269|PubMed:18559978,
CC       ECO:0000269|PubMed:20686069, ECO:0000269|PubMed:20805364,
CC       ECO:0000269|PubMed:21333572}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. SLC46A
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mendelian genes solute carrier family 46
CC       (folate transporter), member 1 (SLC46A1); Note=Leiden Open
CC       Variation Database (LOVD);
CC       URL="http://www.lovd.nl/SLC46A1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK054669; BAB70789.1; -; mRNA.
DR   EMBL; AK074161; BAB84987.1; -; mRNA.
DR   EMBL; DQ496103; ABF47092.1; -; Genomic_DNA.
DR   EMBL; BC010691; AAH10691.1; -; mRNA.
DR   EMBL; AL832613; CAD89945.1; -; mRNA.
DR   CCDS; CCDS74019.1; -. [Q96NT5-2]
DR   CCDS; CCDS74020.1; -. [Q96NT5-1]
DR   RefSeq; NP_001229295.1; NM_001242366.2. [Q96NT5-2]
DR   RefSeq; NP_542400.2; NM_080669.5. [Q96NT5-1]
DR   UniGene; Hs.446689; -.
DR   ProteinModelPortal; Q96NT5; -.
DR   BioGrid; 125236; 2.
DR   IntAct; Q96NT5; 2.
DR   STRING; 9606.ENSP00000395653; -.
DR   BindingDB; Q96NT5; -.
DR   ChEMBL; CHEMBL1795188; -.
DR   DrugBank; DB08878; Aminopterin.
DR   DrugBank; DB00158; Folic Acid.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00795; Sulfasalazine.
DR   GuidetoPHARMACOLOGY; 1213; -.
DR   TCDB; 2.A.1.50.1; the major facilitator superfamily (mfs).
DR   iPTMnet; Q96NT5; -.
DR   PhosphoSitePlus; Q96NT5; -.
DR   SwissPalm; Q96NT5; -.
DR   DMDM; 74732636; -.
DR   MaxQB; Q96NT5; -.
DR   PaxDb; Q96NT5; -.
DR   PeptideAtlas; Q96NT5; -.
DR   PRIDE; Q96NT5; -.
DR   DNASU; 113235; -.
DR   Ensembl; ENST00000612814; ENSP00000480703; ENSG00000076351. [Q96NT5-1]
DR   Ensembl; ENST00000618626; ENSP00000483652; ENSG00000076351. [Q96NT5-2]
DR   GeneID; 113235; -.
DR   KEGG; hsa:113235; -.
DR   UCSC; uc032ezi.2; human. [Q96NT5-1]
DR   CTD; 113235; -.
DR   DisGeNET; 113235; -.
DR   GeneCards; SLC46A1; -.
DR   GeneReviews; SLC46A1; -.
DR   H-InvDB; HIX0022189; -.
DR   HGNC; HGNC:30521; SLC46A1.
DR   HPA; CAB011614; -.
DR   MalaCards; SLC46A1; -.
DR   MIM; 229050; phenotype.
DR   MIM; 611672; gene.
DR   neXtProt; NX_Q96NT5; -.
DR   OpenTargets; ENSG00000076351; -.
DR   Orphanet; 90045; Hereditary folate malabsorption.
DR   PharmGKB; PA162403775; -.
DR   eggNOG; KOG2816; Eukaryota.
DR   eggNOG; ENOG410ZVCA; LUCA.
DR   GeneTree; ENSGT00530000063076; -.
DR   HOGENOM; HOG000054191; -.
DR   HOVERGEN; HBG055334; -.
DR   InParanoid; Q96NT5; -.
DR   KO; K14613; -.
DR   OMA; FANTHAQ; -.
DR   OrthoDB; EOG091G08MP; -.
DR   PhylomeDB; Q96NT5; -.
DR   TreeFam; TF315701; -.
DR   Reactome; R-HSA-196757; Metabolism of folate and pterines.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   GeneWiki; SLC46A1; -.
DR   GenomeRNAi; 113235; -.
DR   PRO; PR:Q96NT5; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000076351; -.
DR   CleanEx; HS_SLC46A1; -.
DR   ExpressionAtlas; Q96NT5; baseline and differential.
DR   Genevisible; Q96NT5; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005542; F:folic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0008517; F:folic acid transporter activity; IDA:UniProtKB.
DR   GO; GO:0015232; F:heme transporter activity; TAS:Reactome.
DR   GO; GO:0015078; F:hydrogen ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0015350; F:methotrexate transporter activity; IC:BHF-UCL.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:1904447; P:folic acid import into cell; IDA:BHF-UCL.
DR   GO; GO:0046655; P:folic acid metabolic process; TAS:Reactome.
DR   GO; GO:0015884; P:folic acid transport; IDA:UniProtKB.
DR   GO; GO:1902600; P:hydrogen ion transmembrane transport; IDA:BHF-UCL.
DR   GO; GO:0098829; P:intestinal folate absorption; IC:BHF-UCL.
DR   GO; GO:0051958; P:methotrexate transport; IDA:BHF-UCL.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR005829; Sugar_transporter_CS.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Disease mutation; Folate-binding; Glycoprotein; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    459       Proton-coupled folate transporter.
FT                                /FTId=PRO_0000084851.
FT   TOPO_DOM      1     24       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     25     48       Helical. {ECO:0000255}.
FT   TOPO_DOM     49     84       Extracellular. {ECO:0000255}.
FT   TRANSMEM     85    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    113       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    114    137       Helical. {ECO:0000255}.
FT   TOPO_DOM    138    145       Extracellular. {ECO:0000255}.
FT   TRANSMEM    146    168       Helical. {ECO:0000255}.
FT   TOPO_DOM    169    180       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    181    203       Helical. {ECO:0000255}.
FT   TOPO_DOM    204    212       Extracellular. {ECO:0000255}.
FT   TRANSMEM    213    236       Helical. {ECO:0000255}.
FT   TOPO_DOM    237    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    288       Helical. {ECO:0000255}.
FT   TOPO_DOM    289    309       Extracellular. {ECO:0000255}.
FT   TRANSMEM    310    328       Helical. {ECO:0000255}.
FT   TOPO_DOM    329    331       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    332    356       Helical. {ECO:0000255}.
FT   TOPO_DOM    357    359       Extracellular. {ECO:0000255}.
FT   TRANSMEM    360    381       Helical. {ECO:0000255}.
FT   TOPO_DOM    382    393       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    394    412       Helical. {ECO:0000255}.
FT   TOPO_DOM    413    424       Extracellular. {ECO:0000255}.
FT   TRANSMEM    425    449       Helical. {ECO:0000255}.
FT   TOPO_DOM    450    459       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES       6      6       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:25053408}.
FT   CARBOHYD     68     68       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:25053408}.
FT   VAR_SEQ     361    388       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016053.
FT   VARIANT     113    113       R -> C (in HFM; loss-of-function
FT                                mutation; targeted to the plasma membrane
FT                                but has significantly impaired folate
FT                                transport activity; dbSNP:rs80338770).
FT                                {ECO:0000269|PubMed:18559978}.
FT                                /FTId=VAR_058210.
FT   VARIANT     113    113       R -> S (in HFM; abolishes folate uptake;
FT                                dbSNP:rs80338770).
FT                                {ECO:0000269|PubMed:17446347}.
FT                                /FTId=VAR_032825.
FT   VARIANT     147    147       G -> R (in HFM; reduces folate uptake to
FT                                13% of normal levels; dbSNP:rs80338771).
FT                                {ECO:0000269|PubMed:17446347}.
FT                                /FTId=VAR_032826.
FT   VARIANT     156    156       D -> Y (in HFM; loss of function measured
FT                                as methotrexate uptake;
FT                                dbSNP:rs281875210).
FT                                {ECO:0000269|PubMed:20805364}.
FT                                /FTId=VAR_067960.
FT   VARIANT     295    295       T -> A (in dbSNP:rs34552966).
FT                                /FTId=VAR_050302.
FT   VARIANT     318    318       S -> R (in HFM; abolishes folate uptake;
FT                                dbSNP:rs80338772).
FT                                {ECO:0000269|PubMed:17446347}.
FT                                /FTId=VAR_032827.
FT   VARIANT     335    335       A -> D (in HFM; loss of function measured
FT                                as methotrexate uptake;
FT                                dbSNP:rs281875208).
FT                                {ECO:0000269|PubMed:21333572}.
FT                                /FTId=VAR_067961.
FT   VARIANT     338    338       G -> R (in HFM; loss of function measured
FT                                as methotrexate uptake;
FT                                dbSNP:rs281875209).
FT                                {ECO:0000269|PubMed:21333572}.
FT                                /FTId=VAR_067962.
FT   VARIANT     376    376       R -> Q (in HFM; abolishes folate uptake;
FT                                dbSNP:rs281875211).
FT                                {ECO:0000269|PubMed:20686069}.
FT                                /FTId=VAR_067963.
FT   VARIANT     376    376       R -> W (in HFM; abolishes folate uptake;
FT                                dbSNP:rs80338773).
FT                                {ECO:0000269|PubMed:17446347}.
FT                                /FTId=VAR_032828.
FT   VARIANT     425    425       P -> R (in HFM; reduces folate uptake to
FT                                3.5% of normal levels; dbSNP:rs80338774).
FT                                {ECO:0000269|PubMed:17446347}.
FT                                /FTId=VAR_032829.
FT   MUTAGEN     109    109       D->A,G,E,K,N,S: Loss of methotrexate
FT                                uptake. {ECO:0000269|PubMed:20805364}.
FT   MUTAGEN     156    156       D->E: Does not affect methotrexate
FT                                uptake. {ECO:0000269|PubMed:20805364}.
FT   MUTAGEN     156    156       D->F,K,N,V,W: Loss of methotrexate
FT                                uptake. {ECO:0000269|PubMed:20805364}.
FT   MUTAGEN     156    156       D->G: 2-fold reduction of methotrexate
FT                                uptake. {ECO:0000269|PubMed:20805364}.
FT   MUTAGEN     156    156       D->S: 8-fold reduction of methotrexate
FT                                uptake. {ECO:0000269|PubMed:20805364}.
FT   MUTAGEN     376    376       R->A,C,E,H,Q,W: Abolishes folate uptake.
FT                                {ECO:0000269|PubMed:20686069}.
FT   CONFLICT    394    394       A -> G (in Ref. 1; BAB84987).
FT                                {ECO:0000305}.
SQ   SEQUENCE   459 AA;  49771 MW;  119F89E9E4ACA5F4 CRC64;
     MEGSASPPEK PRARPAAAVL CRGPVEPLVF LANFALVLQG PLTTQYLWHR FSADLGYNGT
     RQRGGCSNRS ADPTMQEVET LTSHWTLYMN VGGFLVGLFS STLLGAWSDS VGRRPLLVLA
     SLGLLLQALV SVFVVQLQLH VGYFVLGRIL CALLGDFGGL LAASFASVAD VSSSRSRTFR
     MALLEASIGV AGMLASLLGG HWLRAQGYAN PFWLALALLI AMTLYAAFCF GETLKEPKST
     RLFTFRHHRS IVQLYVAPAP EKSRKHLALY SLAIFVVITV HFGAQDILTL YELSTPLCWD
     SKLIGYGSAA QHLPYLTSLL ALKLLQYCLA DAWVAEIGLA FNILGMVVFA FATITPLMFT
     GYGLLFLSLV ITPVIRAKLS KLVRETEQGA LFSAVACVNS LAMLTASGIF NSLYPATLNF
     MKGFPFLLGA GLLLIPAVLI GMLEKADPHL EFQQFPQSP
//
